Grifols (GIKLY) Cash & Equivalents Growth (5y) (2015 - 2025)

Grifols (GIKLY) Cash & Equivalents Growth (5y) (2015 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 5.96%
Dec 31, 2024 -1.76%
Dec 31, 2023 -13.57%
Dec 31, 2022 -11.71%
Dec 31, 2021 25.94%
Dec 31, 2020 -11.21%
Sep 30, 2020 4.00%
Mar 31, 2020 -16.48%
Dec 31, 2019 -3.23%
Dec 31, 2018 4.11%
Sep 30, 2018 0.91%
Jun 30, 2018 4.98%
Mar 31, 2018 -47.46%
Dec 31, 2017 11.20%
Jun 30, 2017 15.33%
Mar 31, 2017 -76.45%
Dec 31, 2016 16.05%
Sep 30, 2016 34.30%
Jun 30, 2016 1.66%
Mar 31, 2016 35.22%